[HTML][HTML] Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review
Background: Since the emergence of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused …
(SARS-CoV-2) from China, the novel coronavirus disease 2019 (COVID-19) has caused …
Improved COVID‐19 outcomes following statin therapy: an updated systematic review and meta‐analysis
Background. Although vaccine rollout for COVID‐19 has been effective in some countries,
there is still an urgent need to reduce disease transmission and severity. We recently carried …
there is still an urgent need to reduce disease transmission and severity. We recently carried …
[PDF][PDF] Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
A Pradelle, S Mainbourg, S Provencher, E Massy… - Biomed …, 2024 - infomed.sn
Background: During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …
[HTML][HTML] Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients
C Diaz-Arocutipa, B Melgar-Talavera… - International Journal of …, 2021 - Elsevier
Objectives There is conflicting evidence about the efficacy of statin use in regard to clinical
outcomes in patients with coronavirus disease 2019 (COVID-19). A systematic review and …
outcomes in patients with coronavirus disease 2019 (COVID-19). A systematic review and …
Systemic inflammation and COVID-19 mortality in patients with major noncommunicable diseases: chronic coronary syndromes, diabetes and obesity
COVID-19 is currently considered an inflammatory disease affecting the entire organism. In
severe forms, an augmented inflammatory response leads to the fulminant “cytokine storm” …
severe forms, an augmented inflammatory response leads to the fulminant “cytokine storm” …
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
The impact of statins on COVID-19 remains unclear. This study aims to investigate whether
statin exposure assessed both in the population and in well-defined cohorts of COVID-19 …
statin exposure assessed both in the population and in well-defined cohorts of COVID-19 …
Diagnosis of SARS-Cov-2 infection by RT-PCR using specimens other than naso-and oropharyngeal swabs: a systematic review and meta-analysis
The rapid and accurate testing of SARS-CoV-2 infection is still crucial to mitigate, and
eventually halt, the spread of this disease. Currently, nasopharyngeal swab (NPS) and …
eventually halt, the spread of this disease. Currently, nasopharyngeal swab (NPS) and …
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
Background The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has profoundly affected the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has profoundly affected the …
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
Background and aims Statin therapy is administered to patients with high cardiovascular
risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID …
risk. These patients are also at risk for severe course of coronavirus disease 2019 (COVID …
The association between the use of statins and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Purpose Previously, we have reported potential clinical benefits with the use of statins in
patients with coronavirus disease 2019 (COVID-19) in a meta-analysis, where there was a …
patients with coronavirus disease 2019 (COVID-19) in a meta-analysis, where there was a …